Caricamento...
Imaging biomarkers of NAFLD, NASH, and fibrosis
BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is a clinicopathologic entity that requires a liver biopsy assessment to diagnose the progressive form of NAFLD called non-alcoholic steatohepatitis (NASH). Liver biopsy is invasive, subject to sampling and interobserver variability, and impracti...
Salvato in:
| Pubblicato in: | Mol Metab |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8324681/ https://ncbi.nlm.nih.gov/pubmed/33460786 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molmet.2021.101167 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|